1 Ebert DD, Cuijpers P, Munoz RF, Baumeister H. Prevention of Mental Health Disorders Using Internet- and Mobile-Based Interventions: A Narrative Review and Recommendations for Future Research. Front Psychiatry. 2017;8:116.
2 Grunerbl A, Muaremi A, Osmani V et al. Smartphone-based recognition of states and state changes in bipolar disorder patients. IEEE J Biomed Health Inform. 2015;19:140–8.
3 Palmier-Claus JE, Ainsworth J, Machin M et al. The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application. BMC Psychiatry. 2012;12:172.
4 Granholm E, Ben-Zeev D, Link PC, Bradshaw KR, Holden JL. Mobile Assessment and Treatment for Schizophrenia (MATS): a pilot trial of an interactive text-messaging intervention for medication adherence, socialization, and auditory hallucinations. Schizophr Bull. 2012;38:414–25.
5 Ferreri F, Bourla A, Mouchabac S, Karila L. e-Addictology: An Overview of New Technologies for Assessing and Intervening in Addictive Behaviors. Front Psychiatry. 2018;9:51.
6 Technological innovations in mental healthcare: harnessing the digital revolution. Br J Psychiatry. 2015;206(4):263.
7 Bhugra D, Tasman A, Pathare S et al. The WPA-Lancet Psychiatry Commission on the Future of Psychiatry. Lancet Psychiatry. 2017;4:775–818.
8 Moja L, Kwag KH, Lytras T et al. Effectiveness of computerized decision support systems linked to electronic health records: a systematic review and meta-analysis. Am J Public Health. 2014;104:e12–22.
9 Litt MD, Cooney NL, Morse P. Ecological momentary assessment (EMA) with treated alcoholics: methodological problems and potential solutions. Health Psychol. 1998;17:48–52.
10 Koutsouleris N, Borgwardt S, Meisenzahl EM, Bottlender R, Moller HJ, Riecher-Rossler A. Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study. Schizophr Bull. 2012;38:1234–46.
11 Drysdale AT, Grosenick L, Downar J et al. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med. 2017;23:28–38.
12 Tekin Erguzel T, Tas C, Cebi M. A wrapper-based approach for feature selection and classification of major depressive disorder-bipolar disorders. Comput Biol Med. 2015;64:127–37.
13 Connor JP, Symons M, Feeney GF, Young RM, Wiles J. The application of machine learning techniques as an adjunct to clinical decision making in alcohol dependence treatment. Subst Use Misuse. 2007;42:2193–206.; Chih MY, Patton T, McTavish FM et al. Predictive modeling of addiction lapses in a mobile health application. J Subst Abuse Treat. 2014;46:29–35.
14 Gibbons RD, Weiss DJ, Pilkonis PA et al. Development of a computerized adaptive test for depression. Arch Gen Psychiatry. 2012;69:1104–12.
15 Gibbons RD, Kupfer D, Frank E, Moore T, Beiser DG, Boudreaux ED. Development of a Computerized Adaptive Test Suicide Scale-The CAT-SS. J Clin Psychiatry. 2017;78:1376–82.
16 Gibbons RD, Weiss DJ, Pilkonis PA et al. Development of the CAT-ANX: a computerized adaptive test for anxiety. Am J Psychiatry. 2014;171:187–94.
17 Philip P, Micoulaud-Franchi JA, Sagaspe P et al. Virtual human as a new diagnostic tool, a proof of concept study in the field of major depressive disorders. Sci Rep. 2017;7:42656.
18 Torous J, Staples P, Onnela JP. Realizing the potential of mobile mental health: new methods for new data in psychiatry. Curr Psychiatry Rep. 2015;17:602.
19 Torous J, Staples P, Shanahan M et al. Utilizing a Personal Smartphone Custom App to Assess the Patient Health Questionnaire-9 (PHQ-9) Depressive Symptoms in Patients With Major Depressive Disorder. JMIR Ment Health. 2015;2:e8.; Onnela JP, Rauch SL. Harnessing Smartphone-Based Digital Phenotyping to Enhance Behavioral and Mental Health. Neuropsychopharmacology. 2016;41:1691–6.
20 Carreiro S, Wittbold K, Indic P, Fang H, Zhang J, Boyer EW. Wearable Biosensors to Detect Physiologic Change During Opioid Use. J Med Toxicol. 2016;12:255–62.
21 Carreiro S, Smelson D, Ranney M et al. Real-time mobile detection of drug use with wearable biosensors: a pilot study. J Med Toxicol. 2015;11:73–9.; Swift RM, Martin CS, Swette L, LaConti A, Kackley N. Studies on a wearable, electronic, transdermal alcohol sensor. Alcohol Clin Exp Res. 1992;16:721–5.
22 Selvam AP, Muthukumar S, Kamakoti V, Prasad S. A wearable biochemical sensor for monitoring alcohol consumption lifestyle through Ethyl glucuronide (EtG) detection in human sweat. Sci Rep. 2016;6:23111.
23 Fletcher RR, Tam S, Omojola O, Redemske R, Kwan J. Wearable sensor platform and mobile application for use in cognitive behavioral therapy for drug addiction and PTSD. Conf Proc IEEE Eng Med Biol Soc. 2011;2011:1802–5.
24 Basnet S, Tamminen M, Lahti T. The feasibility of eHealth in mental health care. J Addict Res Ther. 2014;5(4):205.